InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by MACALUSO MICHAEL, Chairman & CEO. Insider active across 1 company, notably Ampio Pharmaceuticals, Inc.. Cumulatively, 6 filings have been logged. Activity tracked since 11 October 2021. The latest transaction was filed on 1 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations6 total
68,400 shares@ US$0.5716.56% mcap18.0% of flowCommon StockSEC:0001415889-22-000257:0
68,400 shares@ US$0.5716.56% mcap18.0% of flowCommon StockSEC:0001415889-22-000257
43,470 shares@ US$1.6429.56% mcap32.0% of flowCommon StockSEC:0001415889-21-005016:0
43,470 shares@ US$1.6429.56% mcap64.1% of flowCommon StockSEC:0001415889-21-005016
950,000 shares0Common StockSEC:0001415889-21-004870
950,000 shares0Common StockSEC:0001415889-21-004870:0
6 of 6 declarations
About MACALUSO MICHAEL
Michael Macaluso is the CEO and Director of Ampio Pharmaceuticals, Inc. He is responsible for the strategic direction of the company and oversees daily operations. His expertise in the pharmaceutical sector is essential for guiding the development of new treatments.
